Differin Epiduo Acne Gel (Adapalene And Benzoyl Peroxide) (adapalene, adapalene, benzoyl peroxide, benzoyl peroxide)
Rx-to-OTC switch
- Region
- 🇺🇸 US
- Active substance
- adapalene, adapalene, benzoyl peroxide, benzoyl peroxide
- Company
- Galderma Labs Lp
- Status
- Approved
- FDA approval
- Fri 22 May 2026
- Designations
- Rx-to-OTC switch
- Application
- NDA220736
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Fri 22 May 2026🇺🇸 FDA approval
FDA approves Differin Epiduo Acne Gel (Adapalene And Benzoyl Peroxide) (adapalene, adapalene, benzoyl peroxide, benzoyl peroxide): rx-to-otc switch
Galderma Labs Lp; NDA220736; Rx-to-OTC switch; gel · source
Follow Differin Epiduo Acne Gel (Adapalene And Benzoyl Peroxide)
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.